Literature DB >> 15719221

Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice.

Ivan O Medvedev1, Raul R Gainetdinov, Tatyana D Sotnikova, Laura M Bohn, Marc G Caron, Linda A Dykstra.   

Abstract

RATIONALE: The dopamine transporter (DAT) is thought to play a major role in the rewarding effects of cocaine. Therefore, it is surprising that cocaine reveals conditioned effects in DAT knockout (DAT-KO) mice.
OBJECTIVES: To examine these findings further, we obtained complete dose-effect curves for DAT-KO and DAT wild-type (DAT-WT) mice in a cocaine conditioned place preference (CPP) procedure.
METHODS: Congenic C57BL6 background female DAT-KO and DAT-WT mice were conditioned in a three-compartment place preference apparatus. Conditioning consisted of three 30-min sessions with cocaine (2.5, 5.0, 10.0, 20.0, or 40.0 mg/kg) and three 30-min sessions with saline. The distribution of time in each choice compartment was determined after each pair of conditioning sessions (one cocaine and one saline session).
RESULTS: DAT-WT mice revealed CPP over a wide range of cocaine doses (5.0-40 mg/kg), whereas DAT-KO mice revealed CPP over a more restricted range of doses, with consistent CPP only occurring with 10 mg/kg of cocaine.
CONCLUSIONS: CPP for cocaine develops in both DAT-KO and DAT-WT mice; however, the dose range at which CPP develops is much more restricted in DAT-KO mice than in DAT-WT mice. These observations corroborate the significant role of DAT inhibition in cocaine's conditioned effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15719221     DOI: 10.1007/s00213-005-2173-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

Review 1.  Experimental genetic approaches to addiction.

Authors:  Aki Laakso; Amy R Mohn; Raul R Gainetdinov; Marc G Caron
Journal:  Neuron       Date:  2002-10-10       Impact factor: 17.173

Review 2.  Recent biochemical studies of the dopamine transporter--a CNS drug target.

Authors:  M J Kuhar
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

Review 3.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues.

Authors:  T M Tzschentke
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

4.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

Authors:  M C Ritz; R J Lamb; S R Goldberg; M J Kuhar
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

5.  Cocaine self-administration in dopamine-transporter knockout mice.

Authors:  B A Rocha; F Fumagalli; R R Gainetdinov; S R Jones; R Ator; B Giros; G W Miller; M G Caron
Journal:  Nat Neurosci       Date:  1998-06       Impact factor: 24.884

6.  Sex differences in the conditioned rewarding effects of cocaine.

Authors:  Scott J Russo; Shirzad Jenab; Sosimo J Fabian; Eugene D Festa; Lynne M Kemen; Vanya Quinones-Jenab
Journal:  Brain Res       Date:  2003-04-25       Impact factor: 3.252

Review 7.  Monoamine transporter pharmacology and mutant mice.

Authors:  Raul R Gainetdinov; Tatyana D Sotnikova; Marc G Caron
Journal:  Trends Pharmacol Sci       Date:  2002-08       Impact factor: 14.819

8.  Relationship between subjective effects of cocaine and dopamine transporter occupancy.

Authors:  N D Volkow; G J Wang; M W Fischman; R W Foltin; J S Fowler; N N Abumrad; S Vitkun; J Logan; S J Gatley; N Pappas; R Hitzemann; C E Shea
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

9.  Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.

Authors:  R R Gainetdinov; W C Wetsel; S R Jones; E D Levin; M Jaber; M G Caron
Journal:  Science       Date:  1999-01-15       Impact factor: 47.728

Review 10.  Monoamine transporters: from genes to behavior.

Authors:  Raul R Gainetdinov; Marc G Caron
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-09-17       Impact factor: 13.820

View more
  14 in total

1.  Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter.

Authors:  Rong Chen; Michael R Tilley; Hua Wei; Fuwen Zhou; Fu-Ming Zhou; San Ching; Ning Quan; Robert L Stephens; Erik R Hill; Timothy Nottoli; Dawn D Han; Howard H Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

2.  Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine.

Authors:  Amy J Ramsey; Aki Laakso; Michel Cyr; Tatyana D Sotnikova; Ali Salahpour; Ivan O Medvedev; Linda A Dykstra; Raul R Gainetdinov; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2008-01-09       Impact factor: 7.853

3.  The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo.

Authors:  Kate L White; J Elliott Robinson; Hu Zhu; Jeffrey F DiBerto; Prabhakar R Polepally; Jordan K Zjawiony; David E Nichols; C J Malanga; Bryan L Roth
Journal:  J Pharmacol Exp Ther       Date:  2014-10-15       Impact factor: 4.030

4.  Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion.

Authors:  Jermaine D Jones; F Scott Hall; George R Uhl; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2009-12-04       Impact factor: 3.533

5.  Cocaine does not produce reward in absence of dopamine transporter inhibition.

Authors:  Michael R Tilley; Brian O'Neill; Dawn D Han; Howard H Gu
Journal:  Neuroreport       Date:  2009-01-07       Impact factor: 1.837

6.  Gene x abstinence effects on drug cue reactivity in addiction: multimodal evidence.

Authors:  Scott J Moeller; Muhammad A Parvaz; Elena Shumay; Nicasia Beebe-Wang; Anna B Konova; Nelly Alia-Klein; Nora D Volkow; Rita Z Goldstein
Journal:  J Neurosci       Date:  2013-06-12       Impact factor: 6.167

Review 7.  Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse.

Authors:  J Zhu; M E A Reith
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

Review 8.  Opposite regulation of conditioned place preference and intravenous drug self-administration in rodent models: Motivational and non-motivational examples.

Authors:  Thomas A Green; Michael T Bardo
Journal:  Neurosci Biobehav Rev       Date:  2020-06-12       Impact factor: 8.989

Review 9.  Dopamine transporter mutant mice in experimental neuropharmacology.

Authors:  Raul R Gainetdinov
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-05       Impact factor: 3.000

10.  Altered reward circuitry in the norepinephrine transporter knockout mouse.

Authors:  Joseph J Gallagher; Xiaowei Zhang; F Scott Hall; George R Uhl; Elaine L Bearer; Russell E Jacobs
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.